| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 191 | 2024 | 12220 | 4.410 |
Why?
|
| Genetic Predisposition to Disease | 159 | 2024 | 17400 | 3.570 |
Why?
|
| Finland | 104 | 2023 | 602 | 3.520 |
Why?
|
| Polymorphism, Single Nucleotide | 170 | 2024 | 15494 | 3.260 |
Why?
|
| Migraine Disorders | 30 | 2022 | 1620 | 2.720 |
Why?
|
| Genetic Loci | 41 | 2023 | 2572 | 2.200 |
Why?
|
| Genetic Variation | 53 | 2023 | 6540 | 2.130 |
Why?
|
| Migraine with Aura | 14 | 2022 | 203 | 1.940 |
Why?
|
| DNA Copy Number Variations | 19 | 2023 | 1940 | 1.680 |
Why?
|
| Multifactorial Inheritance | 24 | 2022 | 1190 | 1.640 |
Why?
|
| Genetic Association Studies | 29 | 2021 | 2699 | 1.440 |
Why?
|
| Migraine without Aura | 7 | 2018 | 84 | 1.410 |
Why?
|
| Gene Frequency | 40 | 2023 | 3587 | 1.390 |
Why?
|
| Schizophrenia | 24 | 2023 | 6874 | 1.310 |
Why?
|
| Chromosome Mapping | 55 | 2019 | 4742 | 1.280 |
Why?
|
| Quantitative Trait Loci | 30 | 2022 | 2015 | 1.270 |
Why?
|
| Disease | 7 | 2023 | 681 | 1.170 |
Why?
|
| Phenotype | 72 | 2023 | 16331 | 1.100 |
Why?
|
| Genome, Human | 27 | 2021 | 4420 | 1.070 |
Why?
|
| Genotype | 74 | 2022 | 12946 | 0.980 |
Why?
|
| In Situ Hybridization, Fluorescence | 23 | 2001 | 2638 | 0.930 |
Why?
|
| Factor XIII | 7 | 1999 | 59 | 0.900 |
Why?
|
| Haplotypes | 34 | 2023 | 2781 | 0.880 |
Why?
|
| Genetic Markers | 25 | 2020 | 2633 | 0.870 |
Why?
|
| Alleles | 46 | 2023 | 6931 | 0.860 |
Why?
|
| Otosclerosis | 1 | 2023 | 110 | 0.810 |
Why?
|
| Pharyngeal Diseases | 1 | 2023 | 132 | 0.810 |
Why?
|
| Biological Specimen Banks | 9 | 2023 | 707 | 0.790 |
Why?
|
| Mutation | 44 | 2022 | 29717 | 0.790 |
Why?
|
| Humans | 475 | 2024 | 742088 | 0.780 |
Why?
|
| Cluster Headache | 1 | 2021 | 54 | 0.770 |
Why?
|
| Body Height | 10 | 2017 | 1574 | 0.750 |
Why?
|
| Point Mutation | 17 | 2014 | 1624 | 0.740 |
Why?
|
| Genetics, Population | 19 | 2020 | 933 | 0.740 |
Why?
|
| Mutation, Missense | 15 | 2023 | 2556 | 0.720 |
Why?
|
| Genomics | 15 | 2023 | 5692 | 0.720 |
Why?
|
| Factor XIII Deficiency | 5 | 1997 | 16 | 0.710 |
Why?
|
| Respiration Disorders | 1 | 2023 | 370 | 0.690 |
Why?
|
| Lod Score | 15 | 2012 | 615 | 0.690 |
Why?
|
| Epilepsy | 16 | 2022 | 3301 | 0.660 |
Why?
|
| Puberty | 4 | 2017 | 489 | 0.630 |
Why?
|
| Gelsolin | 3 | 2003 | 190 | 0.630 |
Why?
|
| Menarche | 5 | 2017 | 513 | 0.620 |
Why?
|
| Founder Effect | 7 | 2023 | 190 | 0.620 |
Why?
|
| Sequence Analysis, DNA | 22 | 2021 | 4801 | 0.610 |
Why?
|
| DiGeorge Syndrome | 2 | 2022 | 177 | 0.600 |
Why?
|
| Chromosomes, Human, Pair 4 | 8 | 2011 | 374 | 0.570 |
Why?
|
| Pedigree | 41 | 2019 | 4646 | 0.570 |
Why?
|
| Genetic Heterogeneity | 5 | 2016 | 732 | 0.570 |
Why?
|
| Genetic Pleiotropy | 6 | 2021 | 182 | 0.560 |
Why?
|
| Chromosomes, Human, Pair 1 | 11 | 2017 | 657 | 0.560 |
Why?
|
| Databases, Genetic | 13 | 2024 | 1780 | 0.560 |
Why?
|
| Quantitative Trait, Heritable | 11 | 2020 | 544 | 0.560 |
Why?
|
| Chromosomes, Human, Pair 2 | 10 | 2015 | 326 | 0.550 |
Why?
|
| Female | 243 | 2024 | 379592 | 0.550 |
Why?
|
| Male | 236 | 2023 | 349538 | 0.550 |
Why?
|
| Intracranial Aneurysm | 8 | 2014 | 1197 | 0.540 |
Why?
|
| Psychotic Disorders | 4 | 2023 | 3040 | 0.530 |
Why?
|
| Personality | 7 | 2015 | 548 | 0.530 |
Why?
|
| Genetic Linkage | 24 | 2013 | 2422 | 0.510 |
Why?
|
| Population | 5 | 2020 | 142 | 0.510 |
Why?
|
| Case-Control Studies | 49 | 2022 | 21719 | 0.510 |
Why?
|
| Bipolar Disorder | 8 | 2023 | 5024 | 0.500 |
Why?
|
| Exons | 16 | 2016 | 2431 | 0.480 |
Why?
|
| Metabolic Diseases | 3 | 2020 | 657 | 0.480 |
Why?
|
| Polymorphism, Genetic | 27 | 2018 | 4328 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 10 | 3 | 2012 | 287 | 0.470 |
Why?
|
| Nootropic Agents | 3 | 2021 | 160 | 0.470 |
Why?
|
| Ki-67 Antigen | 4 | 2003 | 644 | 0.470 |
Why?
|
| Casein Kinase Idelta | 1 | 2013 | 14 | 0.460 |
Why?
|
| Linkage Disequilibrium | 23 | 2020 | 1995 | 0.460 |
Why?
|
| Membrane Proteins | 17 | 2021 | 7873 | 0.460 |
Why?
|
| Open Reading Frames | 4 | 2018 | 810 | 0.450 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2013 | 102 | 0.450 |
Why?
|
| Personal Health Services | 1 | 2012 | 25 | 0.450 |
Why?
|
| Genetics, Medical | 2 | 2015 | 337 | 0.440 |
Why?
|
| Myoclonic Epilepsies, Progressive | 3 | 2021 | 11 | 0.440 |
Why?
|
| Coronary Artery Disease | 13 | 2023 | 6454 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 8 | 7 | 2011 | 462 | 0.430 |
Why?
|
| Cognition | 17 | 2024 | 6722 | 0.430 |
Why?
|
| Middle Aged | 137 | 2023 | 213127 | 0.430 |
Why?
|
| Premature Birth | 8 | 2023 | 1713 | 0.430 |
Why?
|
| Growth | 2 | 2015 | 376 | 0.430 |
Why?
|
| Adiposity | 6 | 2021 | 1806 | 0.420 |
Why?
|
| Human Genome Project | 3 | 2019 | 192 | 0.420 |
Why?
|
| Lipids | 10 | 2021 | 3302 | 0.420 |
Why?
|
| Growth and Development | 1 | 2012 | 51 | 0.410 |
Why?
|
| Hydrocephalus | 1 | 2018 | 746 | 0.410 |
Why?
|
| Cohort Studies | 53 | 2021 | 40450 | 0.410 |
Why?
|
| Adult | 140 | 2023 | 213712 | 0.410 |
Why?
|
| Triglycerides | 14 | 2021 | 2450 | 0.400 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2019 | 587 | 0.400 |
Why?
|
| Epilepsy, Generalized | 3 | 2019 | 174 | 0.400 |
Why?
|
| Glaucoma, Open-Angle | 3 | 2023 | 711 | 0.390 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 847 | 0.390 |
Why?
|
| Collagen | 17 | 2022 | 2684 | 0.390 |
Why?
|
| Mendelian Randomization Analysis | 9 | 2022 | 963 | 0.390 |
Why?
|
| Cardiovascular Diseases | 15 | 2023 | 15108 | 0.380 |
Why?
|
| Genes | 6 | 2008 | 1892 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2016 | 374 | 0.370 |
Why?
|
| Sequence Deletion | 3 | 2013 | 1526 | 0.370 |
Why?
|
| Cognition Disorders | 6 | 2019 | 4030 | 0.370 |
Why?
|
| Lipid Metabolism | 7 | 2021 | 1887 | 0.370 |
Why?
|
| Lipoproteins, VLDL | 2 | 2021 | 201 | 0.370 |
Why?
|
| Receptors, GABA-A | 3 | 2018 | 627 | 0.370 |
Why?
|
| Awards and Prizes | 1 | 2015 | 375 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 2017 | 462 | 0.360 |
Why?
|
| Educational Status | 4 | 2021 | 2533 | 0.350 |
Why?
|
| CRADD Signaling Adaptor Protein | 2 | 2019 | 6 | 0.350 |
Why?
|
| Genes, Recessive | 5 | 2023 | 642 | 0.340 |
Why?
|
| Abnormalities, Multiple | 4 | 2019 | 1416 | 0.340 |
Why?
|
| Estonia | 5 | 2023 | 53 | 0.340 |
Why?
|
| Multigene Family | 6 | 2020 | 1102 | 0.340 |
Why?
|
| Body Mass Index | 20 | 2022 | 12695 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 17 | 5 | 2005 | 438 | 0.330 |
Why?
|
| Multiple Sclerosis | 11 | 2011 | 3076 | 0.320 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2015 | 3920 | 0.320 |
Why?
|
| Asthma | 4 | 2023 | 5955 | 0.320 |
Why?
|
| Homozygote | 11 | 2022 | 1777 | 0.320 |
Why?
|
| Apolipoproteins B | 8 | 2022 | 373 | 0.320 |
Why?
|
| Cadherins | 3 | 2014 | 906 | 0.310 |
Why?
|
| Heterozygote | 16 | 2023 | 2790 | 0.310 |
Why?
|
| Cholesterol, HDL | 8 | 2019 | 1813 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 19 | 5 | 2010 | 366 | 0.310 |
Why?
|
| Glaucoma | 3 | 2023 | 1152 | 0.310 |
Why?
|
| Risk Factors | 54 | 2024 | 72145 | 0.310 |
Why?
|
| Genetic Testing | 13 | 2018 | 3439 | 0.310 |
Why?
|
| Apolipoprotein E4 | 2 | 2023 | 667 | 0.300 |
Why?
|
| Meta-Analysis as Topic | 8 | 2023 | 1342 | 0.300 |
Why?
|
| Ion Transport | 1 | 2008 | 320 | 0.300 |
Why?
|
| Internet | 3 | 2017 | 3062 | 0.300 |
Why?
|
| Gene Duplication | 2 | 2008 | 330 | 0.300 |
Why?
|
| Headache Disorders | 2 | 2021 | 128 | 0.290 |
Why?
|
| Microsatellite Repeats | 12 | 2014 | 800 | 0.290 |
Why?
|
| Proteins | 10 | 2022 | 6096 | 0.290 |
Why?
|
| Fibrinogen | 3 | 2015 | 894 | 0.290 |
Why?
|
| DNA Methylation | 6 | 2021 | 4282 | 0.290 |
Why?
|
| Genes, myc | 3 | 1997 | 399 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2024 | 11695 | 0.280 |
Why?
|
| Aged | 80 | 2024 | 162944 | 0.280 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 4 | 2018 | 494 | 0.280 |
Why?
|
| Peptide Elongation Factors | 2 | 2017 | 62 | 0.280 |
Why?
|
| Body Size | 4 | 2017 | 461 | 0.270 |
Why?
|
| Chromosomes, Human, X | 2 | 2021 | 296 | 0.270 |
Why?
|
| Europe | 16 | 2019 | 3339 | 0.270 |
Why?
|
| Leukemia | 5 | 2005 | 1507 | 0.270 |
Why?
|
| Adolescent | 55 | 2022 | 85649 | 0.270 |
Why?
|
| Macular Degeneration | 2 | 2023 | 980 | 0.270 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2003 | 798 | 0.270 |
Why?
|
| Models, Genetic | 11 | 2018 | 3493 | 0.270 |
Why?
|
| Calcium Channels | 5 | 2018 | 621 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2016 | 380 | 0.260 |
Why?
|
| Computational Biology | 9 | 2020 | 3518 | 0.260 |
Why?
|
| Geography | 5 | 2019 | 669 | 0.260 |
Why?
|
| Hyperlipidemias | 3 | 2020 | 786 | 0.260 |
Why?
|
| RNA, Messenger | 21 | 2022 | 13029 | 0.260 |
Why?
|
| Molecular Sequence Data | 39 | 2014 | 18112 | 0.250 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2014 | 1016 | 0.250 |
Why?
|
| Thyrotropin | 3 | 2020 | 850 | 0.250 |
Why?
|
| Waist-Hip Ratio | 6 | 2019 | 517 | 0.250 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2003 | 221 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 7 | 4 | 2017 | 321 | 0.250 |
Why?
|
| DNA-Binding Proteins | 7 | 2019 | 9639 | 0.250 |
Why?
|
| Antisocial Personality Disorder | 2 | 2016 | 227 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 11 | 7 | 2017 | 417 | 0.240 |
Why?
|
| HLA Antigens | 6 | 2016 | 1382 | 0.240 |
Why?
|
| Ribonucleoproteins | 3 | 2017 | 381 | 0.240 |
Why?
|
| Mental Disorders | 7 | 2019 | 6587 | 0.240 |
Why?
|
| Anorexia Nervosa | 3 | 2019 | 1286 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 9 | 7 | 2016 | 537 | 0.230 |
Why?
|
| Procollagen-Proline Dioxygenase | 4 | 1997 | 86 | 0.230 |
Why?
|
| Chromosomes, Human | 4 | 2011 | 457 | 0.230 |
Why?
|
| Young Adult | 39 | 2021 | 56350 | 0.230 |
Why?
|
| Heart Diseases | 3 | 2016 | 2789 | 0.230 |
Why?
|
| Base Sequence | 31 | 2017 | 12797 | 0.230 |
Why?
|
| Immunity | 3 | 2018 | 1011 | 0.230 |
Why?
|
| Public Health | 1 | 2017 | 2594 | 0.230 |
Why?
|
| Sleep | 3 | 2014 | 4604 | 0.230 |
Why?
|
| Anthropometry | 4 | 2017 | 1350 | 0.230 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2021 | 1158 | 0.230 |
Why?
|
| Colorectal Neoplasms | 6 | 2019 | 6754 | 0.230 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 1351 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 19 | 2011 | 6171 | 0.220 |
Why?
|
| Duty to Recontact | 1 | 2022 | 20 | 0.220 |
Why?
|
| Tissue Banks | 1 | 2004 | 183 | 0.220 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2023 | 27 | 0.220 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2021 | 1808 | 0.220 |
Why?
|
| Blood Pressure | 6 | 2018 | 8541 | 0.220 |
Why?
|
| DNA, Mitochondrial | 2 | 2021 | 814 | 0.220 |
Why?
|
| DNA | 21 | 2011 | 7289 | 0.220 |
Why?
|
| DNA Mutational Analysis | 11 | 2017 | 4187 | 0.220 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2014 | 164 | 0.220 |
Why?
|
| Dyslipidemias | 3 | 2021 | 848 | 0.220 |
Why?
|
| Cholesterol, LDL | 5 | 2022 | 2354 | 0.220 |
Why?
|
| Introns | 11 | 2021 | 991 | 0.220 |
Why?
|
| Tryptamines | 2 | 2016 | 88 | 0.210 |
Why?
|
| Aged, 80 and over | 37 | 2020 | 57683 | 0.210 |
Why?
|
| Calcitonin | 5 | 1995 | 336 | 0.210 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2002 | 76 | 0.210 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 12071 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 13 | 3 | 1997 | 199 | 0.210 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2021 | 9 | 0.210 |
Why?
|
| Mannose-Binding Lectin | 2 | 2022 | 150 | 0.210 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 6 | 2001 | 142 | 0.210 |
Why?
|
| Child Development Disorders, Pervasive | 4 | 2014 | 615 | 0.210 |
Why?
|
| Coronary Disease | 5 | 2018 | 6078 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2019 | 3306 | 0.200 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 106 | 0.200 |
Why?
|
| Low Tension Glaucoma | 1 | 2021 | 22 | 0.200 |
Why?
|
| Ichthyosis, Lamellar | 2 | 1999 | 11 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2003 | 430 | 0.200 |
Why?
|
| Brain Diseases | 3 | 2018 | 1554 | 0.200 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2022 | 685 | 0.200 |
Why?
|
| Leukemia, Myeloid | 2 | 1996 | 705 | 0.200 |
Why?
|
| Physical Chromosome Mapping | 5 | 2020 | 183 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2017 | 355 | 0.200 |
Why?
|
| Myeloproliferative Disorders | 2 | 2020 | 603 | 0.200 |
Why?
|
| Varicose Veins | 1 | 2023 | 154 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2021 | 78 | 0.200 |
Why?
|
| Gene Expression | 10 | 2016 | 7790 | 0.200 |
Why?
|
| Membrane Glycoproteins | 6 | 2016 | 3769 | 0.190 |
Why?
|
| Transcription, Genetic | 9 | 2018 | 7721 | 0.190 |
Why?
|
| Endothelial Growth Factors | 3 | 1998 | 694 | 0.190 |
Why?
|
| Hyperlipidemia, Familial Combined | 2 | 2016 | 10 | 0.190 |
Why?
|
| Telomere | 3 | 2013 | 909 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 6 | 2017 | 1599 | 0.190 |
Why?
|
| Genomic Structural Variation | 1 | 2021 | 65 | 0.190 |
Why?
|
| Leukocytes | 6 | 2020 | 2039 | 0.190 |
Why?
|
| Gene Expression Profiling | 10 | 2019 | 9410 | 0.190 |
Why?
|
| Cholesterol | 5 | 2021 | 2895 | 0.190 |
Why?
|
| Cytokines | 7 | 2021 | 7317 | 0.190 |
Why?
|
| Crohn Disease | 5 | 2022 | 2301 | 0.190 |
Why?
|
| Receptor, Endothelin A | 2 | 2011 | 58 | 0.190 |
Why?
|
| Intestinal Neoplasms | 1 | 2023 | 319 | 0.190 |
Why?
|
| Mucin-5B | 1 | 2021 | 141 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2020 | 3381 | 0.190 |
Why?
|
| Sex Characteristics | 6 | 2021 | 2585 | 0.190 |
Why?
|
| Proteoglycans | 3 | 2014 | 834 | 0.190 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2001 | 2455 | 0.190 |
Why?
|
| Malocclusion | 1 | 2021 | 130 | 0.180 |
Why?
|
| Australia | 6 | 2012 | 1167 | 0.180 |
Why?
|
| Depressive Disorder, Major | 6 | 2021 | 4628 | 0.180 |
Why?
|
| Exfoliation Syndrome | 1 | 2021 | 111 | 0.180 |
Why?
|
| Expressed Sequence Tags | 3 | 2000 | 255 | 0.180 |
Why?
|
| Peptide Hormones | 1 | 2021 | 134 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 5 | 4 | 2013 | 403 | 0.180 |
Why?
|
| Aspartylglucosylaminase | 5 | 2001 | 5 | 0.180 |
Why?
|
| Hernia, Inguinal | 1 | 2022 | 202 | 0.180 |
Why?
|
| Chromosome Aberrations | 4 | 2017 | 1811 | 0.180 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2003 | 2229 | 0.180 |
Why?
|
| Ichthyosis | 1 | 2000 | 60 | 0.180 |
Why?
|
| Transglutaminases | 2 | 1999 | 194 | 0.180 |
Why?
|
| Ocular Hypertension | 1 | 2021 | 197 | 0.180 |
Why?
|
| Parturition | 3 | 2018 | 436 | 0.180 |
Why?
|
| Acyltransferases | 1 | 2021 | 294 | 0.180 |
Why?
|
| Cation Transport Proteins | 2 | 2013 | 327 | 0.180 |
Why?
|
| Transketolase | 1 | 2019 | 9 | 0.170 |
Why?
|
| Twins, Dizygotic | 3 | 2009 | 236 | 0.170 |
Why?
|
| GTP-Binding Proteins | 2 | 2021 | 970 | 0.170 |
Why?
|
| Haploinsufficiency | 2 | 2019 | 329 | 0.170 |
Why?
|
| Aging | 5 | 2020 | 8626 | 0.170 |
Why?
|
| Cosmids | 7 | 1998 | 107 | 0.170 |
Why?
|
| Lissencephaly | 1 | 2019 | 38 | 0.170 |
Why?
|
| Inheritance Patterns | 5 | 2019 | 340 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 22 | 4 | 2017 | 351 | 0.170 |
Why?
|
| Body Fluid Compartments | 1 | 2019 | 52 | 0.170 |
Why?
|
| Principal Component Analysis | 4 | 2016 | 939 | 0.170 |
Why?
|
| Biostatistics | 1 | 2020 | 160 | 0.170 |
Why?
|
| Shaw Potassium Channels | 2 | 2017 | 19 | 0.170 |
Why?
|
| Cloning, Molecular | 10 | 1998 | 4322 | 0.170 |
Why?
|
| Atherosclerosis | 4 | 2022 | 3428 | 0.170 |
Why?
|
| RNA-Binding Proteins | 5 | 2022 | 1899 | 0.160 |
Why?
|
| Family Health | 6 | 2019 | 1282 | 0.160 |
Why?
|
| Apolipoproteins E | 3 | 2019 | 1438 | 0.160 |
Why?
|
| Hypertriglyceridemia | 2 | 2019 | 293 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2017 | 323 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2021 | 2915 | 0.160 |
Why?
|
| Kidney Neoplasms | 4 | 2005 | 4229 | 0.160 |
Why?
|
| Smoking | 5 | 2015 | 8969 | 0.160 |
Why?
|
| Biological Psychiatry | 1 | 2017 | 25 | 0.160 |
Why?
|
| Centromere | 2 | 2015 | 220 | 0.160 |
Why?
|
| DNA Primers | 9 | 2003 | 2892 | 0.160 |
Why?
|
| Animals | 45 | 2023 | 168561 | 0.150 |
Why?
|
| Fibrinolysis | 1 | 1999 | 322 | 0.150 |
Why?
|
| Intraocular Pressure | 2 | 2021 | 1274 | 0.150 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2017 | 67 | 0.150 |
Why?
|
| Alcoholism | 3 | 2020 | 1904 | 0.150 |
Why?
|
| Twins, Monozygotic | 3 | 2012 | 458 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 7 | 2021 | 4465 | 0.150 |
Why?
|
| Verbal Learning | 2 | 2022 | 466 | 0.150 |
Why?
|
| Puberty, Delayed | 2 | 2008 | 115 | 0.150 |
Why?
|
| Aortic Aneurysm | 1 | 2022 | 643 | 0.150 |
Why?
|
| Genetic Drift | 2 | 2014 | 43 | 0.150 |
Why?
|
| Neuroendocrine Tumors | 1 | 2023 | 594 | 0.150 |
Why?
|
| Sex Factors | 11 | 2020 | 10392 | 0.150 |
Why?
|
| Infant, Newborn | 15 | 2024 | 25575 | 0.150 |
Why?
|
| Amino Acid Sequence | 16 | 2020 | 13814 | 0.150 |
Why?
|
| Frameshift Mutation | 2 | 1996 | 399 | 0.150 |
Why?
|
| Recombination, Genetic | 3 | 2020 | 1586 | 0.150 |
Why?
|
| Adipose Tissue | 4 | 2019 | 3278 | 0.140 |
Why?
|
| Lysosomal Storage Diseases | 4 | 2001 | 79 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 1996 | 31 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2022 | 895 | 0.140 |
Why?
|
| Models, Molecular | 5 | 2020 | 5454 | 0.140 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1889 | 0.140 |
Why?
|
| Maternal-Child Health Centers | 1 | 1996 | 40 | 0.140 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome | 1 | 2016 | 9 | 0.140 |
Why?
|
| Age of Onset | 8 | 2021 | 3266 | 0.140 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2016 | 91 | 0.140 |
Why?
|
| Jews | 1 | 2018 | 385 | 0.140 |
Why?
|
| Alzheimer Disease | 5 | 2023 | 7988 | 0.140 |
Why?
|
| Antigens, CD34 | 1 | 1998 | 657 | 0.140 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2016 | 83 | 0.140 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2016 | 30 | 0.140 |
Why?
|
| Plasma | 1 | 2019 | 575 | 0.140 |
Why?
|
| Speech | 1 | 2021 | 540 | 0.140 |
Why?
|
| Intermediate Filament Proteins | 1 | 2017 | 269 | 0.140 |
Why?
|
| Rare Diseases | 2 | 2018 | 554 | 0.140 |
Why?
|
| Fragile X Mental Retardation Protein | 2 | 2014 | 117 | 0.140 |
Why?
|
| Biology | 1 | 2018 | 292 | 0.140 |
Why?
|
| Sciatica | 1 | 2016 | 98 | 0.140 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 972 | 0.130 |
Why?
|
| ABO Blood-Group System | 2 | 2021 | 367 | 0.130 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 325 | 0.130 |
Why?
|
| Epilepsies, Partial | 1 | 2019 | 436 | 0.130 |
Why?
|
| Connexin 43 | 1 | 2016 | 206 | 0.130 |
Why?
|
| Anemia, Macrocytic | 1 | 1995 | 55 | 0.130 |
Why?
|
| Microfilament Proteins | 3 | 2016 | 1152 | 0.130 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2015 | 15 | 0.130 |
Why?
|
| Denmark | 4 | 2019 | 736 | 0.130 |
Why?
|
| Child | 30 | 2021 | 77478 | 0.130 |
Why?
|
| Hyperlipoproteinemia Type II | 3 | 2017 | 373 | 0.130 |
Why?
|
| Epilepsy, Absence | 1 | 2015 | 48 | 0.130 |
Why?
|
| Gestational Age | 2 | 2017 | 3490 | 0.130 |
Why?
|
| Translocation, Genetic | 3 | 2017 | 1417 | 0.130 |
Why?
|
| HMGN1 Protein | 1 | 2015 | 27 | 0.130 |
Why?
|
| Receptors, Neuropeptide | 1 | 2015 | 111 | 0.130 |
Why?
|
| Fetus | 4 | 2016 | 1879 | 0.130 |
Why?
|
| Dyssomnias | 1 | 2014 | 29 | 0.130 |
Why?
|
| Reproducibility of Results | 16 | 2019 | 19862 | 0.130 |
Why?
|
| Epilepsy, Reflex | 1 | 2015 | 26 | 0.130 |
Why?
|
| Acetylglucosamine | 1 | 1996 | 191 | 0.130 |
Why?
|
| Blood Coagulation | 2 | 2013 | 1126 | 0.130 |
Why?
|
| Transcortin | 1 | 2014 | 13 | 0.130 |
Why?
|
| Personality Inventory | 3 | 2012 | 1026 | 0.120 |
Why?
|
| Sepharose | 1 | 1994 | 108 | 0.120 |
Why?
|
| Long QT Syndrome | 2 | 2009 | 453 | 0.120 |
Why?
|
| Obesity | 7 | 2021 | 12705 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 689 | 0.120 |
Why?
|
| Chromosomes, Artificial, Yeast | 5 | 1999 | 118 | 0.120 |
Why?
|
| Spasms, Infantile | 2 | 2016 | 305 | 0.120 |
Why?
|
| Seafood | 1 | 2017 | 384 | 0.120 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2014 | 22 | 0.120 |
Why?
|
| Granulocytes | 1 | 1996 | 546 | 0.120 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 170 | 0.120 |
Why?
|
| Receptors, Nicotinic | 2 | 2014 | 497 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2021 | 3585 | 0.120 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 3639 | 0.120 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 1452 | 0.120 |
Why?
|
| Basement Membrane | 3 | 1984 | 356 | 0.120 |
Why?
|
| Platelet Activation | 1 | 1998 | 671 | 0.120 |
Why?
|
| Receptors, CXCR3 | 1 | 2015 | 237 | 0.120 |
Why?
|
| Monoamine Oxidase | 1 | 2014 | 178 | 0.120 |
Why?
|
| Hypercalcemia | 1 | 2017 | 405 | 0.120 |
Why?
|
| Prevalence | 7 | 2020 | 15194 | 0.120 |
Why?
|
| Ovarian Follicle | 2 | 1987 | 247 | 0.120 |
Why?
|
| Cytidine Deaminase | 1 | 2016 | 251 | 0.120 |
Why?
|
| Transcription Factors | 9 | 2019 | 12164 | 0.120 |
Why?
|
| Hypercholesterolemia | 2 | 2019 | 1149 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 8 | 2021 | 5867 | 0.120 |
Why?
|
| Body Weight | 2 | 2017 | 4664 | 0.120 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 1184 | 0.120 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 5 | 1999 | 143 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 437 | 0.120 |
Why?
|
| Lipoproteins, LDL | 4 | 2020 | 628 | 0.120 |
Why?
|
| HEK293 Cells | 4 | 2023 | 4200 | 0.120 |
Why?
|
| Fiber Optic Technology | 1 | 1995 | 289 | 0.120 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 4 | 1999 | 335 | 0.120 |
Why?
|
| Chromosome Deletion | 3 | 2013 | 1400 | 0.120 |
Why?
|
| Optic Atrophy | 1 | 2014 | 79 | 0.120 |
Why?
|
| Hemiplegia | 2 | 2004 | 135 | 0.120 |
Why?
|
| Zinc Fingers | 2 | 2012 | 585 | 0.120 |
Why?
|
| Genes, Dominant | 3 | 2014 | 880 | 0.120 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2017 | 306 | 0.120 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2015 | 265 | 0.120 |
Why?
|
| Thinness | 1 | 2017 | 479 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2020 | 4553 | 0.120 |
Why?
|
| Glycoproteins | 5 | 2021 | 2260 | 0.120 |
Why?
|
| Software | 5 | 2019 | 4434 | 0.120 |
Why?
|
| Gene Rearrangement | 4 | 2006 | 1179 | 0.120 |
Why?
|
| Leigh Disease | 1 | 2014 | 75 | 0.120 |
Why?
|
| Anxiety Disorders | 2 | 2015 | 2684 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2290 | 0.110 |
Why?
|
| Stroke | 6 | 2017 | 9963 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2906 | 0.110 |
Why?
|
| Fasting | 2 | 2017 | 1589 | 0.110 |
Why?
|
| Evolution, Molecular | 3 | 2011 | 1937 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 582 | 0.110 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 1246 | 0.110 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 3 | 1997 | 60 | 0.110 |
Why?
|
| Carrier Proteins | 5 | 2023 | 5019 | 0.110 |
Why?
|
| Insulin | 4 | 2017 | 6575 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2003 | 2842 | 0.110 |
Why?
|
| Intelligence | 1 | 2018 | 920 | 0.110 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2013 | 80 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 807 | 0.110 |
Why?
|
| Hashimoto Disease | 1 | 2014 | 93 | 0.110 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2013 | 69 | 0.110 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 1179 | 0.110 |
Why?
|
| Muscle Proteins | 2 | 2016 | 1159 | 0.110 |
Why?
|
| Hemochromatosis | 2 | 2008 | 184 | 0.110 |
Why?
|
| Celiac Disease | 1 | 2021 | 785 | 0.110 |
Why?
|
| Somatoform Disorders | 1 | 2016 | 423 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 2 | 2014 | 497 | 0.110 |
Why?
|
| Polymorphism, Restriction Fragment Length | 7 | 1991 | 768 | 0.110 |
Why?
|
| Odds Ratio | 9 | 2017 | 9846 | 0.110 |
Why?
|
| Learning | 1 | 2022 | 1705 | 0.110 |
Why?
|
| Depression | 4 | 2023 | 7733 | 0.110 |
Why?
|
| Population Groups | 2 | 2010 | 208 | 0.110 |
Why?
|
| Data Mining | 2 | 2023 | 537 | 0.110 |
Why?
|
| Suicide | 2 | 2022 | 1475 | 0.110 |
Why?
|
| Insulin Resistance | 3 | 2017 | 3861 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 1860 | 0.110 |
Why?
|
| Genes, ras | 2 | 1993 | 691 | 0.110 |
Why?
|
| Methylation | 6 | 2012 | 1107 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 1675 | 0.110 |
Why?
|
| Body Composition | 2 | 2019 | 2400 | 0.110 |
Why?
|
| Graves Disease | 1 | 2014 | 241 | 0.100 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2013 | 246 | 0.100 |
Why?
|
| Mice | 23 | 2023 | 81045 | 0.100 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2012 | 126 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2013 | 182 | 0.100 |
Why?
|
| Iodide Peroxidase | 1 | 2014 | 293 | 0.100 |
Why?
|
| Prognosis | 13 | 2020 | 29010 | 0.100 |
Why?
|
| Ataxia | 1 | 2014 | 304 | 0.100 |
Why?
|
| RNA Splicing | 1 | 1997 | 907 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 933 | 0.100 |
Why?
|
| Oligodendroglia | 1 | 2015 | 514 | 0.100 |
Why?
|
| Gene Regulatory Networks | 4 | 2019 | 1707 | 0.100 |
Why?
|
| Gene Dosage | 3 | 2023 | 1251 | 0.100 |
Why?
|
| alpha Catenin | 1 | 2011 | 38 | 0.100 |
Why?
|
| Karyotyping | 5 | 2017 | 1243 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2005 | 3123 | 0.100 |
Why?
|
| Aquaporins | 1 | 2012 | 174 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 670 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 836 | 0.100 |
Why?
|
| Candidiasis | 2 | 2005 | 365 | 0.100 |
Why?
|
| Waist Circumference | 1 | 2015 | 917 | 0.100 |
Why?
|
| Growth Disorders | 3 | 2008 | 643 | 0.100 |
Why?
|
| Desmosomes | 1 | 2011 | 73 | 0.100 |
Why?
|
| Cerebellum | 3 | 2016 | 1490 | 0.100 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2015 | 403 | 0.100 |
Why?
|
| Chorionic Gonadotropin | 3 | 2008 | 474 | 0.100 |
Why?
|
| Synapses | 3 | 2017 | 1724 | 0.100 |
Why?
|
| Ubiquitin | 1 | 2016 | 849 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2012 | 300 | 0.100 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 3957 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 875 | 0.100 |
Why?
|
| Liver | 5 | 2021 | 7470 | 0.100 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1337 | 0.100 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 1413 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4751 | 0.100 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2010 | 60 | 0.100 |
Why?
|
| Metabolomics | 3 | 2022 | 1467 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1728 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2014 | 3760 | 0.100 |
Why?
|
| Gene Pool | 1 | 2010 | 35 | 0.100 |
Why?
|
| DNA-Directed DNA Polymerase | 3 | 2012 | 484 | 0.090 |
Why?
|
| Hyperthyroidism | 1 | 2013 | 293 | 0.090 |
Why?
|
| Infant | 16 | 2021 | 35070 | 0.090 |
Why?
|
| Serum | 1 | 2012 | 212 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 377 | 0.090 |
Why?
|
| Hypertension | 3 | 2021 | 8455 | 0.090 |
Why?
|
| Lipoproteins | 3 | 2011 | 876 | 0.090 |
Why?
|
| Frontal Lobe | 2 | 2016 | 1407 | 0.090 |
Why?
|
| Hostility | 1 | 2011 | 189 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1057 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2017 | 2924 | 0.090 |
Why?
|
| Family | 7 | 2019 | 3144 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 4 | 2016 | 1655 | 0.090 |
Why?
|
| Blood Platelets | 2 | 1998 | 2506 | 0.090 |
Why?
|
| Fatty Acids | 2 | 2017 | 1806 | 0.090 |
Why?
|
| Serpins | 2 | 2003 | 247 | 0.090 |
Why?
|
| Siblings | 3 | 2011 | 854 | 0.090 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 653 | 0.090 |
Why?
|
| Receptors, Androgen | 2 | 2012 | 1057 | 0.090 |
Why?
|
| Temperament | 1 | 2012 | 283 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2021 | 3695 | 0.090 |
Why?
|
| Brain Ischemia | 2 | 2015 | 3258 | 0.090 |
Why?
|
| Age Factors | 10 | 2017 | 18355 | 0.090 |
Why?
|
| Sweden | 3 | 2006 | 1343 | 0.090 |
Why?
|
| Apolipoprotein B-100 | 3 | 2020 | 148 | 0.090 |
Why?
|
| Chronic Disease | 6 | 2023 | 9144 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3649 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2502 | 0.090 |
Why?
|
| Germany | 3 | 2019 | 860 | 0.090 |
Why?
|
| Environment | 2 | 2008 | 1115 | 0.090 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2012 | 248 | 0.090 |
Why?
|
| Biological Clocks | 1 | 2012 | 322 | 0.090 |
Why?
|
| Complement C7 | 1 | 2009 | 17 | 0.090 |
Why?
|
| Brain | 10 | 2022 | 26343 | 0.090 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2011 | 161 | 0.090 |
Why?
|
| Analgesics | 1 | 2016 | 1037 | 0.090 |
Why?
|
| Mental Processes | 1 | 2010 | 249 | 0.090 |
Why?
|
| Psychomotor Agitation | 1 | 2011 | 288 | 0.090 |
Why?
|
| Protein Kinase C-alpha | 2 | 2007 | 112 | 0.090 |
Why?
|
| Lipoprotein Lipase | 2 | 2003 | 125 | 0.090 |
Why?
|
| Myocardial Infarction | 4 | 2015 | 11690 | 0.080 |
Why?
|
| Potassium Channels | 1 | 2012 | 562 | 0.080 |
Why?
|
| Thyroxine | 1 | 2013 | 666 | 0.080 |
Why?
|
| Breast Neoplasms | 6 | 2020 | 20774 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 1060 | 0.080 |
Why?
|
| Hypothyroidism | 2 | 2013 | 659 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2857 | 0.080 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2009 | 141 | 0.080 |
Why?
|
| Inflammation | 2 | 2023 | 10578 | 0.080 |
Why?
|
| Arm | 1 | 2012 | 589 | 0.080 |
Why?
|
| Molecular Biology | 1 | 1993 | 595 | 0.080 |
Why?
|
| Hemoglobin, Sickle | 1 | 2009 | 122 | 0.080 |
Why?
|
| Scotoma | 1 | 2010 | 139 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2015 | 1533 | 0.080 |
Why?
|
| Versicans | 2 | 2019 | 33 | 0.080 |
Why?
|
| Gene Deletion | 3 | 2013 | 2751 | 0.080 |
Why?
|
| Osteoarthritis | 3 | 1993 | 1034 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2017 | 2128 | 0.080 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2008 | 73 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2000 | 281 | 0.080 |
Why?
|
| Adolescent Development | 1 | 2012 | 277 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 390 | 0.080 |
Why?
|
| Neoplasms | 5 | 2020 | 21596 | 0.080 |
Why?
|
| Influenza A virus | 1 | 2012 | 456 | 0.080 |
Why?
|
| Comorbidity | 7 | 2021 | 10372 | 0.080 |
Why?
|
| Violence | 1 | 2014 | 908 | 0.080 |
Why?
|
| Risk | 6 | 2021 | 9679 | 0.080 |
Why?
|
| Astrocytes | 1 | 2015 | 1266 | 0.080 |
Why?
|
| Primates | 1 | 2010 | 543 | 0.080 |
Why?
|
| International Cooperation | 5 | 2018 | 1421 | 0.080 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 655 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 944 | 0.080 |
Why?
|
| Pan troglodytes | 1 | 2008 | 229 | 0.080 |
Why?
|
| Colitis, Ulcerative | 2 | 2019 | 1901 | 0.080 |
Why?
|
| Telomerase | 1 | 2013 | 729 | 0.080 |
Why?
|
| Molecular Epidemiology | 3 | 2018 | 468 | 0.080 |
Why?
|
| Cause of Death | 3 | 2015 | 3571 | 0.080 |
Why?
|
| Selection, Genetic | 2 | 2012 | 914 | 0.080 |
Why?
|
| Pregnancy | 12 | 2024 | 29087 | 0.080 |
Why?
|
| Diabetes Mellitus | 3 | 2021 | 5724 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 782 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2008 | 1366 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 1999 | 230 | 0.080 |
Why?
|
| Histocompatibility | 1 | 2009 | 330 | 0.080 |
Why?
|
| Leptin | 1 | 2016 | 1593 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1155 | 0.080 |
Why?
|
| Microbial Collagenase | 2 | 1987 | 122 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2024 | 3731 | 0.080 |
Why?
|
| Procollagen | 6 | 1993 | 185 | 0.080 |
Why?
|
| Transferrin | 1 | 2008 | 295 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2020 | 1144 | 0.080 |
Why?
|
| Lipase | 2 | 2020 | 315 | 0.080 |
Why?
|
| Pseudogenes | 2 | 1997 | 113 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2012 | 6249 | 0.080 |
Why?
|
| Eye Proteins | 2 | 2021 | 644 | 0.080 |
Why?
|
| Ovulation | 2 | 1987 | 189 | 0.080 |
Why?
|
| Factor V | 2 | 1999 | 174 | 0.080 |
Why?
|
| Endothelin-1 | 1 | 2009 | 313 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2014 | 1183 | 0.070 |
Why?
|
| Eye Abnormalities | 2 | 2019 | 246 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 4566 | 0.070 |
Why?
|
| Myosins | 1 | 2009 | 409 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2004 | 1086 | 0.070 |
Why?
|
| Databases, Factual | 6 | 2019 | 7716 | 0.070 |
Why?
|
| Medical History Taking | 2 | 2022 | 783 | 0.070 |
Why?
|
| Immunohistochemistry | 7 | 2015 | 11363 | 0.070 |
Why?
|
| Child, Preschool | 13 | 2021 | 40955 | 0.070 |
Why?
|
| DNA, Complementary | 7 | 1999 | 2049 | 0.070 |
Why?
|
| Time Factors | 10 | 2020 | 40054 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 2274 | 0.070 |
Why?
|
| Models, Neurological | 2 | 2014 | 1771 | 0.070 |
Why?
|
| Plasminogen Activators | 1 | 1987 | 209 | 0.070 |
Why?
|
| Registries | 6 | 2021 | 8077 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2015 | 2739 | 0.070 |
Why?
|
| Antigens, Neoplasm | 4 | 2003 | 1983 | 0.070 |
Why?
|
| Molecular Sequence Annotation | 2 | 2022 | 527 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2012 | 1121 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2015 | 1499 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 1184 | 0.070 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2009 | 425 | 0.070 |
Why?
|
| Twins | 4 | 2012 | 339 | 0.070 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2007 | 154 | 0.070 |
Why?
|
| Pregnancy Complications | 3 | 2012 | 2861 | 0.070 |
Why?
|
| Head | 1 | 2012 | 878 | 0.070 |
Why?
|
| Follow-Up Studies | 10 | 2022 | 39004 | 0.070 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 1997 | 120 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2014 | 1825 | 0.070 |
Why?
|
| Genome | 3 | 2009 | 1803 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2001 | 1659 | 0.070 |
Why?
|
| Health Surveys | 2 | 2013 | 4030 | 0.070 |
Why?
|
| Biological Evolution | 1 | 2012 | 1074 | 0.070 |
Why?
|
| Executive Function | 1 | 2015 | 1362 | 0.070 |
Why?
|
| Taste | 1 | 2007 | 175 | 0.070 |
Why?
|
| Death, Sudden | 2 | 2015 | 298 | 0.070 |
Why?
|
| Demyelinating Diseases | 1 | 2008 | 363 | 0.070 |
Why?
|
| Contracture | 2 | 1998 | 223 | 0.070 |
Why?
|
| Longitudinal Studies | 6 | 2020 | 13921 | 0.070 |
Why?
|
| Mothers | 2 | 2023 | 2163 | 0.070 |
Why?
|
| Thyroid Gland | 1 | 2013 | 1172 | 0.070 |
Why?
|
| Risk Assessment | 8 | 2020 | 23320 | 0.070 |
Why?
|
| Prospective Studies | 11 | 2022 | 53187 | 0.070 |
Why?
|
| Sensitivity and Specificity | 7 | 2011 | 14720 | 0.070 |
Why?
|
| Tachycardia, Ventricular | 1 | 2014 | 1272 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 874 | 0.070 |
Why?
|
| Syndrome | 8 | 2019 | 3248 | 0.070 |
Why?
|
| Heparitin Sulfate | 2 | 1983 | 225 | 0.070 |
Why?
|
| Severity of Illness Index | 7 | 2021 | 15530 | 0.070 |
Why?
|
| Autoantibodies | 1 | 2014 | 2036 | 0.070 |
Why?
|
| Protein Conformation | 4 | 2020 | 4013 | 0.070 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2006 | 284 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 2011 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2013 | 1837 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1995 | 1351 | 0.060 |
Why?
|
| COS Cells | 2 | 1997 | 1160 | 0.060 |
Why?
|
| X Chromosome | 3 | 1998 | 815 | 0.060 |
Why?
|
| Amino Acid Substitution | 3 | 2019 | 1792 | 0.060 |
Why?
|
| Sequence Homology | 2 | 2020 | 203 | 0.060 |
Why?
|
| Metabolome | 1 | 2012 | 881 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2011 | 1606 | 0.060 |
Why?
|
| Mitochondria | 2 | 2014 | 3520 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 3 | 2017 | 1081 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2016 | 2410 | 0.060 |
Why?
|
| Japan | 3 | 2014 | 1360 | 0.060 |
Why?
|
| Polyendocrinopathies, Autoimmune | 2 | 1997 | 55 | 0.060 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2004 | 19 | 0.060 |
Why?
|
| Smell | 1 | 2007 | 243 | 0.060 |
Why?
|
| Aorta | 2 | 2022 | 2057 | 0.060 |
Why?
|
| Laminin | 3 | 1999 | 418 | 0.060 |
Why?
|
| Lipoproteins, HDL | 3 | 2017 | 637 | 0.060 |
Why?
|
| Codon | 2 | 1997 | 611 | 0.060 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2008 | 364 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4933 | 0.060 |
Why?
|
| Conserved Sequence | 3 | 2017 | 1202 | 0.060 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2004 | 43 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2003 | 8425 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 2 | 2021 | 935 | 0.060 |
Why?
|
| Signal Transduction | 6 | 2017 | 23387 | 0.060 |
Why?
|
| Netherlands | 2 | 2011 | 2170 | 0.060 |
Why?
|
| Lymphokines | 2 | 1998 | 949 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 3 | 2021 | 1363 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2011 | 3139 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4147 | 0.060 |
Why?
|
| Genomic Imprinting | 2 | 2017 | 331 | 0.060 |
Why?
|
| Quality Control | 4 | 2010 | 841 | 0.060 |
Why?
|
| GPI-Linked Proteins | 2 | 2017 | 434 | 0.060 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2003 | 31 | 0.060 |
Why?
|
| Menopause | 1 | 2012 | 1621 | 0.060 |
Why?
|
| Acetazolamide | 1 | 2004 | 100 | 0.060 |
Why?
|
| Cells, Cultured | 10 | 2019 | 19223 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2019 | 849 | 0.060 |
Why?
|
| Scotland | 2 | 2015 | 155 | 0.060 |
Why?
|
| Food Preferences | 1 | 2007 | 399 | 0.060 |
Why?
|
| Fibronectins | 3 | 1990 | 723 | 0.060 |
Why?
|
| Sample Size | 3 | 2016 | 844 | 0.060 |
Why?
|
| Calcium | 1 | 2017 | 5753 | 0.060 |
Why?
|
| Vestibular Nerve | 1 | 2003 | 101 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 1638 | 0.060 |
Why?
|
| Twin Studies as Topic | 1 | 2003 | 105 | 0.060 |
Why?
|
| Songbirds | 1 | 2003 | 17 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 4250 | 0.060 |
Why?
|
| Demography | 1 | 2008 | 1650 | 0.060 |
Why?
|
| Lymphocytes | 3 | 2020 | 2614 | 0.060 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 1983 | 130 | 0.060 |
Why?
|
| Tissue Array Analysis | 1 | 2005 | 553 | 0.060 |
Why?
|
| Apolipoprotein C-III | 2 | 2022 | 202 | 0.060 |
Why?
|
| Antigens, Surface | 2 | 2022 | 1663 | 0.060 |
Why?
|
| Population Surveillance | 3 | 2018 | 2616 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2022 | 8297 | 0.060 |
Why?
|
| Cell Line | 8 | 2022 | 15994 | 0.060 |
Why?
|
| Contig Mapping | 2 | 2001 | 54 | 0.060 |
Why?
|
| Neuropsychological Tests | 5 | 2015 | 6974 | 0.050 |
Why?
|
| Restriction Mapping | 4 | 1999 | 878 | 0.050 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 32 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2015 | 3740 | 0.050 |
Why?
|
| Sequence Alignment | 4 | 2014 | 2257 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2014 | 2971 | 0.050 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2002 | 87 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2006 | 577 | 0.050 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2002 | 76 | 0.050 |
Why?
|
| Fragile X Syndrome | 2 | 2001 | 115 | 0.050 |
Why?
|
| RNA Splice Sites | 1 | 2003 | 209 | 0.050 |
Why?
|
| INDEL Mutation | 2 | 2015 | 279 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2186 | 0.050 |
Why?
|
| Retinal Dystrophies | 1 | 2023 | 58 | 0.050 |
Why?
|
| DNA Repair | 1 | 2012 | 2042 | 0.050 |
Why?
|
| Carbonic Anhydrases | 1 | 2003 | 115 | 0.050 |
Why?
|
| Phylogeny | 3 | 2020 | 2797 | 0.050 |
Why?
|
| Arthritis, Reactive | 1 | 2002 | 19 | 0.050 |
Why?
|
| Endoderm | 1 | 1983 | 150 | 0.050 |
Why?
|
| Blotting, Southern | 3 | 1998 | 803 | 0.050 |
Why?
|
| Spondylarthropathies | 1 | 2002 | 14 | 0.050 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2022 | 32 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 2337 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2003 | 2948 | 0.050 |
Why?
|
| Metaphase | 3 | 1999 | 151 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 8829 | 0.050 |
Why?
|
| Cerebellar Ataxia | 1 | 2003 | 145 | 0.050 |
Why?
|
| Reference Values | 5 | 2016 | 4982 | 0.050 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15056 | 0.050 |
Why?
|
| Central Nervous System | 2 | 2022 | 1354 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2021 | 2504 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 7 | 2002 | 6313 | 0.050 |
Why?
|
| Heat-Shock Proteins | 2 | 2014 | 822 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 169 | 0.050 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide)-Phosphatase | 1 | 2021 | 4 | 0.050 |
Why?
|
| Nerve Net | 1 | 2014 | 2174 | 0.050 |
Why?
|
| Cerebellar Diseases | 1 | 2003 | 222 | 0.050 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2014 | 3748 | 0.050 |
Why?
|
| Genes, Lethal | 2 | 1998 | 242 | 0.050 |
Why?
|
| Carnitine | 1 | 2022 | 239 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2019 | 2713 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 10163 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor C | 2 | 1998 | 126 | 0.050 |
Why?
|
| Logistic Models | 6 | 2017 | 13403 | 0.050 |
Why?
|
| Connexins | 1 | 2023 | 359 | 0.050 |
Why?
|
| Serpin E2 | 1 | 2020 | 48 | 0.050 |
Why?
|
| Genome, Mitochondrial | 1 | 2021 | 71 | 0.050 |
Why?
|
| Placenta | 2 | 2024 | 1694 | 0.050 |
Why?
|
| Algorithms | 5 | 2023 | 13853 | 0.050 |
Why?
|
| Blepharophimosis | 1 | 2000 | 22 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2006 | 740 | 0.050 |
Why?
|
| Endothelium | 1 | 1983 | 778 | 0.050 |
Why?
|
| Overweight | 1 | 2012 | 2366 | 0.050 |
Why?
|
| Bilirubin | 1 | 2022 | 424 | 0.050 |
Why?
|
| CpG Islands | 2 | 2017 | 1170 | 0.050 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 135 | 0.050 |
Why?
|
| Parents | 1 | 2014 | 3387 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2022 | 315 | 0.050 |
Why?
|
| Muscle Hypotonia | 2 | 2019 | 165 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2017 | 6452 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3239 | 0.050 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2021 | 90 | 0.050 |
Why?
|
| Glycosaminoglycans | 1 | 1983 | 624 | 0.050 |
Why?
|
| Metabolism, Inborn Errors | 2 | 1998 | 288 | 0.050 |
Why?
|
| Goiter | 1 | 2020 | 86 | 0.050 |
Why?
|
| Thyroglobulin | 1 | 2020 | 114 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2021 | 200 | 0.050 |
Why?
|
| Trinucleotide Repeats | 2 | 1998 | 261 | 0.050 |
Why?
|
| Ichthyosiform Erythroderma, Congenital | 1 | 1999 | 7 | 0.050 |
Why?
|
| Anxiety | 1 | 2014 | 4279 | 0.040 |
Why?
|
| European Union | 2 | 2015 | 157 | 0.040 |
Why?
|
| RNA | 3 | 2022 | 2747 | 0.040 |
Why?
|
| Neurologic Examination | 3 | 2010 | 931 | 0.040 |
Why?
|
| Anticonvulsants | 2 | 2013 | 1914 | 0.040 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2021 | 172 | 0.040 |
Why?
|
| Ganglioglioma | 1 | 2019 | 42 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2003 | 3691 | 0.040 |
Why?
|
| Heart Failure | 1 | 2023 | 10856 | 0.040 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 2 | 2009 | 70 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2000 | 2645 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 1998 | 772 | 0.040 |
Why?
|
| Eye | 1 | 2023 | 728 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2014 | 2837 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2003 | 1146 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4229 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3455 | 0.040 |
Why?
|
| Hypoventilation | 1 | 2019 | 38 | 0.040 |
Why?
|
| Primary Dysautonomias | 1 | 2019 | 25 | 0.040 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 1999 | 32 | 0.040 |
Why?
|
| Malaria | 1 | 2009 | 1232 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 7923 | 0.040 |
Why?
|
| Marfan Syndrome | 2 | 1992 | 240 | 0.040 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1996 | 689 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 210 | 0.040 |
Why?
|
| Life Style | 2 | 2022 | 3824 | 0.040 |
Why?
|
| Meningocele | 1 | 1999 | 45 | 0.040 |
Why?
|
| Amine Oxidase (Copper-Containing) | 1 | 1998 | 41 | 0.040 |
Why?
|
| Polydactyly | 1 | 1999 | 57 | 0.040 |
Why?
|
| Pain | 1 | 2013 | 4961 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 1704 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2019 | 129 | 0.040 |
Why?
|
| Hemosiderosis | 1 | 1998 | 71 | 0.040 |
Why?
|
| Cefotaxime | 1 | 2017 | 35 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2066 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 2 | 2023 | 3574 | 0.040 |
Why?
|
| Sequence Analysis | 2 | 2009 | 256 | 0.040 |
Why?
|
| Motor Neuron Disease | 1 | 1998 | 106 | 0.040 |
Why?
|
| Gene Flow | 1 | 2018 | 79 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2017 | 33 | 0.040 |
Why?
|
| DNA, Neoplasm | 2 | 1995 | 1758 | 0.040 |
Why?
|
| Fetal Growth Retardation | 2 | 1998 | 570 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2017 | 98 | 0.040 |
Why?
|
| Encephalocele | 1 | 1999 | 135 | 0.040 |
Why?
|
| Dwarfism | 1 | 1999 | 145 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 1123 | 0.040 |
Why?
|
| DNA Probes | 2 | 1995 | 560 | 0.040 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 1997 | 64 | 0.040 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2017 | 55 | 0.040 |
Why?
|
| Population Density | 1 | 2018 | 194 | 0.040 |
Why?
|
| Isomerases | 1 | 1997 | 56 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1988 | 170 | 0.040 |
Why?
|
| Fatty Acid Desaturases | 1 | 1997 | 102 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 664 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 1999 | 450 | 0.040 |
Why?
|
| Syndecans | 1 | 1997 | 79 | 0.040 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2017 | 88 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 98 | 0.040 |
Why?
|
| Carcinoma, Papillary | 1 | 2002 | 781 | 0.040 |
Why?
|
| Mass Screening | 1 | 2013 | 5238 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2013 | 898 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2016 | 14554 | 0.040 |
Why?
|
| Austria | 1 | 2017 | 201 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2009 | 2951 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2019 | 316 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2017 | 245 | 0.040 |
Why?
|
| Models, Animal | 1 | 2004 | 2170 | 0.040 |
Why?
|
| Mental Recall | 1 | 2023 | 1205 | 0.040 |
Why?
|
| HLA-DR Antigens | 2 | 2011 | 644 | 0.040 |
Why?
|
| Coronary Thrombosis | 1 | 2000 | 494 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 154 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12344 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 176 | 0.040 |
Why?
|
| NFI Transcription Factors | 1 | 2016 | 44 | 0.040 |
Why?
|
| Histone Code | 1 | 2017 | 163 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 1999 | 508 | 0.040 |
Why?
|
| Hypoparathyroidism | 1 | 1997 | 120 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2014 | 1541 | 0.040 |
Why?
|
| Cataract | 1 | 2023 | 833 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2000 | 1003 | 0.040 |
Why?
|
| Infertility, Female | 1 | 2023 | 784 | 0.040 |
Why?
|
| Aminopeptidases | 1 | 1996 | 88 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 1997 | 167 | 0.030 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1996 | 88 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2019 | 600 | 0.030 |
Why?
|
| Electronic Health Records | 2 | 2023 | 4440 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 1999 | 471 | 0.030 |
Why?
|
| Bone Marrow | 3 | 1996 | 2941 | 0.030 |
Why?
|
| Mandible | 1 | 2021 | 740 | 0.030 |
Why?
|
| Syndecan-1 | 1 | 1997 | 164 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2016 | 1780 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1992 | 3497 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 186 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2005 | 10248 | 0.030 |
Why?
|
| Receptor, Insulin | 2 | 2014 | 846 | 0.030 |
Why?
|
| Receptors, TIE | 1 | 1995 | 10 | 0.030 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 351 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 2699 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2015 | 5180 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 2885 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1999 | 768 | 0.030 |
Why?
|
| Access to Information | 1 | 2019 | 320 | 0.030 |
Why?
|
| Hypotonic Solutions | 1 | 1995 | 49 | 0.030 |
Why?
|
| Thioredoxins | 1 | 1997 | 213 | 0.030 |
Why?
|
| Pteridines | 1 | 2015 | 45 | 0.030 |
Why?
|
| Criminals | 1 | 2016 | 62 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2023 | 1221 | 0.030 |
Why?
|
| Copper | 3 | 1983 | 366 | 0.030 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 5851 | 0.030 |
Why?
|
| Acute Disease | 4 | 2005 | 7141 | 0.030 |
Why?
|
| Coenzymes | 1 | 2015 | 91 | 0.030 |
Why?
|
| Metalloproteins | 1 | 2015 | 100 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 504 | 0.030 |
Why?
|
| Centrifugation | 1 | 1995 | 122 | 0.030 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 1995 | 54 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 971 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 508 | 0.030 |
Why?
|
| Xanthine Dehydrogenase | 1 | 1995 | 16 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 902 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2017 | 563 | 0.030 |
Why?
|
| Birth Weight | 1 | 2023 | 2068 | 0.030 |
Why?
|
| Dimerization | 1 | 1997 | 893 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 604 | 0.030 |
Why?
|
| Ovary | 2 | 2014 | 981 | 0.030 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1994 | 16 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2017 | 475 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2003 | 3847 | 0.030 |
Why?
|
| Thrombosis | 1 | 2009 | 2966 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2019 | 727 | 0.030 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1997 | 255 | 0.030 |
Why?
|
| Apolipoproteins C | 1 | 1994 | 59 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 291 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 995 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2016 | 237 | 0.030 |
Why?
|
| Histocytochemistry | 3 | 1984 | 718 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2019 | 1122 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1987 | 2191 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 748 | 0.030 |
Why?
|
| Orosomucoid | 1 | 2014 | 45 | 0.030 |
Why?
|
| Polylysine | 1 | 1994 | 133 | 0.030 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 3766 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 67 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2022 | 827 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2009 | 5425 | 0.030 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 1218 | 0.030 |
Why?
|
| Leukemia, Lymphoid | 1 | 1994 | 313 | 0.030 |
Why?
|
| Morbidity | 1 | 2020 | 1767 | 0.030 |
Why?
|
| Genetic Code | 1 | 2014 | 154 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 316 | 0.030 |
Why?
|
| Prostate | 1 | 2002 | 1764 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 58 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2019 | 62966 | 0.030 |
Why?
|
| Tobacco Use Disorder | 1 | 2020 | 685 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2014 | 151 | 0.030 |
Why?
|
| Aspartylglucosaminuria | 1 | 1993 | 2 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2001 | 1232 | 0.030 |
Why?
|
| Memory | 1 | 2024 | 2163 | 0.030 |
Why?
|
| Transfection | 2 | 2004 | 5892 | 0.030 |
Why?
|
| Arabs | 1 | 1996 | 177 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 1145 | 0.030 |
Why?
|
| Protein-Lysine 6-Oxidase | 3 | 1983 | 60 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 126 | 0.030 |
Why?
|
| Headache | 1 | 2021 | 1219 | 0.030 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2014 | 101 | 0.030 |
Why?
|
| tau Proteins | 1 | 2023 | 1860 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 232 | 0.030 |
Why?
|
| Erythroid Precursor Cells | 1 | 1994 | 218 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2014 | 581 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1676 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2016 | 435 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2938 | 0.030 |
Why?
|
| Education | 1 | 2016 | 543 | 0.030 |
Why?
|
| Plasmalogens | 1 | 2013 | 31 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1020 | 0.030 |
Why?
|
| Lipoprotein(a) | 1 | 2017 | 425 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 1 | 1995 | 420 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 1994 | 229 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2005 | 2956 | 0.030 |
Why?
|
| Calcineurin | 1 | 2014 | 226 | 0.030 |
Why?
|
| Liver Diseases | 2 | 1998 | 1252 | 0.030 |
Why?
|
| Finger Joint | 1 | 1993 | 108 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 88 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2014 | 180 | 0.030 |
Why?
|
| Prions | 1 | 2014 | 181 | 0.030 |
Why?
|
| Apolipoprotein A-II | 1 | 2012 | 39 | 0.030 |
Why?
|
| Isoantibodies | 1 | 1997 | 680 | 0.030 |
Why?
|
| MADS Domain Proteins | 1 | 2012 | 20 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2019 | 1426 | 0.030 |
Why?
|
| Consanguinity | 2 | 2012 | 456 | 0.030 |
Why?
|
| Sulfites | 1 | 2012 | 77 | 0.030 |
Why?
|
| Zebrafish | 2 | 2015 | 2990 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 676 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2014 | 223 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 1995 | 548 | 0.030 |
Why?
|
| Thrombocythemia, Essential | 1 | 1994 | 103 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 1726 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2020 | 1294 | 0.030 |
Why?
|
| Linear Models | 2 | 2013 | 5948 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1997 | 1099 | 0.030 |
Why?
|
| Lysine | 1 | 1997 | 1008 | 0.030 |
Why?
|
| Prostatic Neoplasms | 3 | 2020 | 11039 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 2013 | 291 | 0.030 |
Why?
|
| Seizures, Febrile | 1 | 2013 | 111 | 0.030 |
Why?
|
| Longevity | 1 | 2020 | 1069 | 0.030 |
Why?
|
| Benzene | 1 | 1992 | 100 | 0.030 |
Why?
|
| Polycythemia Vera | 1 | 1994 | 163 | 0.030 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2012 | 106 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 780 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2015 | 361 | 0.030 |
Why?
|
| Microcephaly | 1 | 2016 | 430 | 0.030 |
Why?
|
| Sex Ratio | 1 | 2012 | 110 | 0.030 |
Why?
|
| Protein Folding | 1 | 1996 | 843 | 0.030 |
Why?
|
| Chromosome Breakage | 1 | 2012 | 173 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1997 | 1118 | 0.030 |
Why?
|
| Electrocardiography | 3 | 2011 | 6440 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2018 | 983 | 0.030 |
Why?
|
| ras Proteins | 1 | 2017 | 1060 | 0.030 |
Why?
|
| Influenza B virus | 1 | 2012 | 49 | 0.030 |
Why?
|
| Oxycodone | 1 | 2013 | 152 | 0.030 |
Why?
|
| Polysomnography | 1 | 2018 | 1772 | 0.030 |
Why?
|
| Models, Statistical | 3 | 2014 | 5100 | 0.030 |
Why?
|
| Larva | 1 | 2013 | 517 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 24913 | 0.030 |
Why?
|
| Turkey | 1 | 2012 | 237 | 0.030 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2012 | 89 | 0.030 |
Why?
|
| Primary Myelofibrosis | 1 | 1994 | 214 | 0.030 |
Why?
|
| Neurofibromatosis 2 | 1 | 1995 | 380 | 0.030 |
Why?
|
| Connective Tissue Diseases | 3 | 1988 | 264 | 0.030 |
Why?
|
| Desmoglein 2 | 1 | 2011 | 12 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 2425 | 0.030 |
Why?
|
| Reaction Time | 1 | 2018 | 2092 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 109 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1213 | 0.020 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1982 | 151 | 0.020 |
Why?
|
| Receptors, FSH | 1 | 2011 | 28 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 480 | 0.020 |
Why?
|
| Endophenotypes | 1 | 2013 | 250 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 1636 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2012 | 140 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 231 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2253 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2012 | 242 | 0.020 |
Why?
|
| Plakophilins | 1 | 2011 | 34 | 0.020 |
Why?
|
| Magnetics | 1 | 1994 | 609 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2012 | 212 | 0.020 |
Why?
|
| Desmoplakins | 1 | 2011 | 62 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 1996 | 1073 | 0.020 |
Why?
|
| Immune System Diseases | 1 | 2013 | 262 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1786 | 0.020 |
Why?
|
| Ammonia-Lyases | 1 | 1990 | 6 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2011 | 228 | 0.020 |
Why?
|
| Hydroxymethylbilane Synthase | 1 | 1990 | 7 | 0.020 |
Why?
|
| Blast Crisis | 1 | 1991 | 103 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2012 | 314 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2014 | 674 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2021 | 77098 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2016 | 2723 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 176 | 0.020 |
Why?
|
| England | 1 | 2012 | 523 | 0.020 |
Why?
|
| Diet, Mediterranean | 1 | 2017 | 696 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2012 | 311 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 1123 | 0.020 |
Why?
|
| Fibroblasts | 4 | 2016 | 4143 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2015 | 1049 | 0.020 |
Why?
|
| Porphyrias | 1 | 1990 | 57 | 0.020 |
Why?
|
| Amino Acids | 2 | 2012 | 1727 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1995 | 1062 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2023 | 4983 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1988 | 0.020 |
Why?
|
| Spain | 1 | 2011 | 465 | 0.020 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2010 | 77 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 707 | 0.020 |
Why?
|
| Species Specificity | 1 | 2014 | 2479 | 0.020 |
Why?
|
| Neurons | 2 | 2022 | 9325 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 688 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 244 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4414 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2013 | 774 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 905 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 703 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1653 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 1995 | 1684 | 0.020 |
Why?
|
| Health Behavior | 1 | 2022 | 2630 | 0.020 |
Why?
|
| Biosynthetic Pathways | 1 | 2010 | 137 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 1699 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 1998 | 3502 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 349 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2019 | 1852 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 143 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 2 | 2001 | 2712 | 0.020 |
Why?
|
| Prostaglandins | 1 | 2010 | 405 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1802 | 0.020 |
Why?
|
| Hypersensitivity | 2 | 2010 | 1093 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 3504 | 0.020 |
Why?
|
| Particle Size | 1 | 2014 | 1640 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 828 | 0.020 |
Why?
|
| Gambia | 1 | 2009 | 98 | 0.020 |
Why?
|
| Kidney | 2 | 2003 | 7167 | 0.020 |
Why?
|
| Osteogenesis Imperfecta | 2 | 1980 | 83 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2010 | 270 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 9581 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2009 | 128 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 623 | 0.020 |
Why?
|
| Plasmids | 1 | 1994 | 2305 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3020 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2011 | 6030 | 0.020 |
Why?
|
| Angiopoietin-1 | 2 | 2001 | 114 | 0.020 |
Why?
|
| Keratins | 1 | 2010 | 515 | 0.020 |
Why?
|
| Hot Temperature | 2 | 2013 | 1355 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1613 | 0.020 |
Why?
|
| Molecular Weight | 2 | 2007 | 2255 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 1123 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2119 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 721 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 4455 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2015 | 1317 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2009 | 104 | 0.020 |
Why?
|
| Basophils | 1 | 2010 | 389 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2009 | 298 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2012 | 584 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2012 | 981 | 0.020 |
Why?
|
| Coronary Vessels | 2 | 2015 | 3099 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 1374 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2015 | 2027 | 0.020 |
Why?
|
| Gene Conversion | 1 | 2008 | 71 | 0.020 |
Why?
|
| Testis | 2 | 2003 | 800 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2012 | 729 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2013 | 575 | 0.020 |
Why?
|
| Test Anxiety Scale | 1 | 2007 | 3 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2003 | 3456 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2001 | 4029 | 0.020 |
Why?
|
| Causality | 1 | 2014 | 1265 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 457 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 1997 | 1799 | 0.020 |
Why?
|
| Gonadotropins, Equine | 1 | 1987 | 7 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 686 | 0.020 |
Why?
|
| Propylthiouracil | 1 | 2007 | 69 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2014 | 830 | 0.020 |
Why?
|
| Chromatin | 1 | 2019 | 2917 | 0.020 |
Why?
|
| Genomic Library | 2 | 1997 | 193 | 0.020 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2007 | 19 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2008 | 232 | 0.020 |
Why?
|
| Arteries | 1 | 2012 | 1118 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1995 | 2017 | 0.020 |
Why?
|
| Menkes Kinky Hair Syndrome | 2 | 1983 | 20 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2009 | 742 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2723 | 0.020 |
Why?
|
| Action Potentials | 1 | 2014 | 1814 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 503 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 2075 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3528 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2010 | 810 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1790 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4554 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2012 | 861 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 1470 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2020 | 2774 | 0.020 |
Why?
|
| Health Resources | 1 | 2012 | 911 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 1992 | 1413 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 986 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 2867 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 21821 | 0.020 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 1983 | 89 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2009 | 1835 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2017 | 2024 | 0.020 |
Why?
|
| Autophagy | 1 | 2013 | 1301 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 1987 | 265 | 0.020 |
Why?
|
| Mastectomy | 1 | 2013 | 1789 | 0.020 |
Why?
|
| Epithelium | 2 | 2001 | 1680 | 0.020 |
Why?
|
| Norway | 1 | 2006 | 446 | 0.020 |
Why?
|
| Gene Library | 2 | 1998 | 1076 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2004 | 3127 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2015 | 3199 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 2006 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1996 | 2749 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 2120 | 0.020 |
Why?
|
| Rats | 3 | 2004 | 24265 | 0.020 |
Why?
|
| Electronystagmography | 1 | 2003 | 24 | 0.020 |
Why?
|
| Glioma | 1 | 2019 | 3388 | 0.020 |
Why?
|
| Epidermolysis Bullosa | 1 | 1984 | 25 | 0.020 |
Why?
|
| Blindness | 1 | 1988 | 615 | 0.010 |
Why?
|
| Virus Replication | 1 | 2012 | 2531 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2013 | 3418 | 0.010 |
Why?
|
| Brain Diseases, Metabolic | 1 | 1983 | 42 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3548 | 0.010 |
Why?
|
| Autoradiography | 1 | 1984 | 749 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 730 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1983 | 218 | 0.010 |
Why?
|
| Weight Loss | 1 | 2014 | 2604 | 0.010 |
Why?
|
| Mast Cells | 1 | 2010 | 1544 | 0.010 |
Why?
|
| Remission Induction | 1 | 2009 | 2384 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1983 | 118 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 2005 | 4839 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6534 | 0.010 |
Why?
|
| Sex Differentiation | 1 | 2003 | 73 | 0.010 |
Why?
|
| Audiometry | 1 | 2003 | 242 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1990 | 1111 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6365 | 0.010 |
Why?
|
| Vocalization, Animal | 1 | 2003 | 87 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1983 | 347 | 0.010 |
Why?
|
| Psychometrics | 1 | 2012 | 2999 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 2003 | 105 | 0.010 |
Why?
|
| Data Collection | 1 | 2012 | 3339 | 0.010 |
Why?
|
| Ocular Motility Disorders | 1 | 2004 | 135 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2003 | 166 | 0.010 |
Why?
|
| Anesthesia | 1 | 2013 | 1548 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1423 | 0.010 |
Why?
|
| Fatal Outcome | 2 | 1997 | 1849 | 0.010 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 1982 | 15 | 0.010 |
Why?
|
| Malonates | 1 | 1982 | 42 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1984 | 420 | 0.010 |
Why?
|
| Candida | 1 | 2003 | 172 | 0.010 |
Why?
|
| Vertigo | 1 | 2003 | 201 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1996 | 8925 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1992 | 1794 | 0.010 |
Why?
|
| Radiography | 2 | 1993 | 7010 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9387 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5133 | 0.010 |
Why?
|
| Glucose | 1 | 2014 | 4391 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 457 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 2005 | 582 | 0.010 |
Why?
|
| Stochastic Processes | 1 | 2003 | 344 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1984 | 864 | 0.010 |
Why?
|
| Seizures | 1 | 2014 | 2851 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2964 | 0.010 |
Why?
|
| United States | 3 | 2017 | 69693 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 2763 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 5979 | 0.010 |
Why?
|
| Lac Operon | 1 | 2001 | 238 | 0.010 |
Why?
|
| Health Status | 1 | 2014 | 4030 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2014 | 5978 | 0.010 |
Why?
|
| Dizziness | 1 | 2004 | 250 | 0.010 |
Why?
|
| Scleroderma, Systemic | 1 | 1985 | 313 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 126 | 0.010 |
Why?
|
| Gene Order | 1 | 2001 | 176 | 0.010 |
Why?
|
| Macrophages | 1 | 2015 | 5655 | 0.010 |
Why?
|
| Bone Diseases, Developmental | 1 | 1982 | 130 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2013 | 1668 | 0.010 |
Why?
|
| Receptor, TIE-2 | 1 | 2001 | 178 | 0.010 |
Why?
|
| Patient Selection | 1 | 2013 | 4214 | 0.010 |
Why?
|
| Influenza, Human | 1 | 2012 | 1472 | 0.010 |
Why?
|
| Canada | 1 | 2006 | 2061 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 20928 | 0.010 |
Why?
|
| Hypotension | 1 | 2006 | 880 | 0.010 |
Why?
|
| Eye Movements | 1 | 2003 | 506 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1983 | 1456 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2714 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 642 | 0.010 |
Why?
|
| Iron | 1 | 2008 | 1773 | 0.010 |
Why?
|
| Teratoma | 1 | 1983 | 387 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 9715 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2015 | 6142 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2009 | 2041 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2009 | 2205 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 4211 | 0.010 |
Why?
|
| Binding Sites | 2 | 1999 | 6115 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 2203 | 0.010 |
Why?
|
| Accidents | 1 | 2000 | 164 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2005 | 11001 | 0.010 |
Why?
|
| Retinoids | 1 | 1999 | 96 | 0.010 |
Why?
|
| Postural Balance | 1 | 2003 | 620 | 0.010 |
Why?
|
| Septins | 1 | 1999 | 54 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 1950 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 711 | 0.010 |
Why?
|
| Codon, Initiator | 1 | 1998 | 52 | 0.010 |
Why?
|
| Osteoporosis | 1 | 1988 | 1581 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12242 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 552 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2010 | 3461 | 0.010 |
Why?
|
| Peptides | 2 | 2002 | 4392 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1997 | 94 | 0.010 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 1997 | 32 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 2 | 1988 | 570 | 0.010 |
Why?
|
| Titrimetry | 1 | 1997 | 36 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1998 | 318 | 0.010 |
Why?
|
| Cattle | 1 | 1983 | 3923 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 3667 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2001 | 600 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2001 | 3014 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1998 | 318 | 0.010 |
Why?
|
| Acidosis, Lactic | 1 | 1998 | 142 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2010 | 6191 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3701 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2003 | 1049 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 1996 | 27 | 0.010 |
Why?
|
| RNA Helicases | 1 | 1997 | 142 | 0.010 |
Why?
|
| Colorimetry | 1 | 1997 | 147 | 0.010 |
Why?
|
| Fetal Death | 1 | 1998 | 447 | 0.010 |
Why?
|
| Autopsy | 1 | 2000 | 1006 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 6474 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2001 | 671 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13256 | 0.010 |
Why?
|
| Hypocalcemia | 1 | 1997 | 191 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 1638 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1727 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 1581 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1827 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 1997 | 509 | 0.010 |
Why?
|
| Genistein | 1 | 1995 | 84 | 0.010 |
Why?
|
| Asparagine | 1 | 1995 | 122 | 0.010 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 1997 | 198 | 0.010 |
Why?
|
| Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1995 | 7 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 1997 | 348 | 0.010 |
Why?
|
| Chromans | 1 | 1995 | 122 | 0.010 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 1995 | 124 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 2986 | 0.010 |
Why?
|
| Neck | 1 | 1999 | 693 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1995 | 278 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2003 | 2906 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 441 | 0.010 |
Why?
|
| Isoflavones | 1 | 1995 | 139 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 794 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1997 | 515 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 2335 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 35342 | 0.010 |
Why?
|
| Leg | 1 | 1999 | 1110 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 2459 | 0.010 |
Why?
|
| California | 1 | 1998 | 1400 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10472 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4024 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5385 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11470 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2003 | 2107 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 2012 | 3236 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1998 | 851 | 0.010 |
Why?
|
| Lung | 1 | 2012 | 9826 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 821 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1987 | 3843 | 0.010 |
Why?
|
| Cysteine | 1 | 1997 | 873 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1992 | 156 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1993 | 427 | 0.010 |
Why?
|
| Body Burden | 1 | 1992 | 158 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2001 | 2051 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8436 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6382 | 0.010 |
Why?
|
| Serine | 1 | 1995 | 828 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 2187 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 1995 | 450 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1995 | 13019 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5062 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1997 | 1801 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1997 | 683 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1801 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 6891 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1998 | 1807 | 0.010 |
Why?
|
| Skin | 2 | 1999 | 4353 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2126 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 1997 | 859 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1995 | 1608 | 0.010 |
Why?
|
| Recurrence | 1 | 2001 | 8333 | 0.010 |
Why?
|
| Phenols | 1 | 1992 | 501 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 1988 | 115 | 0.010 |
Why?
|
| Elastin | 1 | 1990 | 305 | 0.010 |
Why?
|
| Muscles | 1 | 1993 | 1617 | 0.000 |
Why?
|
| Estradiol | 1 | 1995 | 2021 | 0.000 |
Why?
|
| Cartilage, Articular | 1 | 1993 | 1095 | 0.000 |
Why?
|
| Respiration | 1 | 1992 | 1645 | 0.000 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 1985 | 8 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1995 | 3420 | 0.000 |
Why?
|
| Glucosyltransferases | 1 | 1985 | 98 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1997 | 1912 | 0.000 |
Why?
|
| Metallothionein | 1 | 1983 | 59 | 0.000 |
Why?
|
| Myocardium | 1 | 1997 | 4775 | 0.000 |
Why?
|
| Phenytoin | 1 | 1984 | 197 | 0.000 |
Why?
|
| Galactosyltransferases | 1 | 1985 | 263 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1995 | 2211 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 3862 | 0.000 |
Why?
|
| Malonyl Coenzyme A | 1 | 1982 | 20 | 0.000 |
Why?
|
| Occipital Bone | 1 | 1982 | 54 | 0.000 |
Why?
|
| Acyl Coenzyme A | 1 | 1982 | 55 | 0.000 |
Why?
|
| Urinary Bladder Diseases | 1 | 1982 | 166 | 0.000 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1982 | 361 | 0.000 |
Why?
|
| Diverticulum | 1 | 1982 | 136 | 0.000 |
Why?
|
| Mannose | 1 | 1980 | 124 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 9274 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1980 | 237 | 0.000 |
Why?
|
| Circular Dichroism | 1 | 1980 | 354 | 0.000 |
Why?
|
| Culture Media | 1 | 1980 | 902 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1995 | 9185 | 0.000 |
Why?
|
| Joint Instability | 1 | 1982 | 792 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1980 | 5095 | 0.000 |
Why?
|